Acucela, Strengthening Ties With Otsuka, Gets Right to Develop New Drug

Little biotech companies usually discover new drugs, and hand them off for development to a Big Pharma company with cash and expertise in running clinical trials. But one of the Seattle area’s little biotech companies, Acucela, is doing the exact opposite, and doing it in a profitable way.
Xconomy